当前位置: 首页 > 详情页

A Primary Proteomic Analysis of Serum from Patients with Nonfunctioning Pituitary Adenoma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [2]Beijing Normal Univ, Med Res Inst, Beijing 100875, Peoples R China; [3]Univ Confederated, Inst Prote, Beijing, Peoples R China; [4]Peoples Liberat Army, Gen Hosp Artillery Force 2, Dept Endocrinol, Beijing, Peoples R China; [5]Peoples Liberat Army, Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [6]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [7]Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai St, Beijing 100875, Peoples R China
出处:
ISSN:

关键词: NON-FUNCTIONING PITUITARY ADENOMA (NFPA) TUMOUR BIOMARKER SERUM DIAGNOSIS DECISION TREE CLASSIFICATION PROTEOMICS PROTEIN CHIP SURFACE-ENHANCED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY (SELDI-TOF-MS)

摘要:
OBJECTIVE: The early diagnosis of nonfunctioning pituitary adenoma (NFPA) is difficult. The objective of this study was to find specific protein biomarkers to aid in the early detection of NFPA. METHODS: Serum samples from 34 patients with NFPA and 34 age- and sex-matched healthy control subjects were analysed using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology. The spectra were generated, protein peak clustering was performed and classification analyses were carried out using a decision tree classification algorithm. RESULTS: Nine differentially expressed serum proteins were identified in the patients with NFPA compared with the control subjects. Both the sensitivity and specificity of the decision tree classification algorithm were 82.4% for NFPA. CONCLUSIONS: Nine new serum protein biomarkers for NFPA were identified. SELDI-TOF-MS coupled with data mining tools might provide a novel approach for the early diagnosis of NFPA and population screening for the disease.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2010]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [2]Beijing Normal Univ, Med Res Inst, Beijing 100875, Peoples R China; [3]Univ Confederated, Inst Prote, Beijing, Peoples R China; [4]Peoples Liberat Army, Gen Hosp Artillery Force 2, Dept Endocrinol, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [2]Beijing Normal Univ, Med Res Inst, Beijing 100875, Peoples R China; [3]Univ Confederated, Inst Prote, Beijing, Peoples R China; [7]Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai St, Beijing 100875, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院